3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
434
Head & Neck
8
Gynecologic
6
Thoracic
5
Genitourinary
5
Dermatologic
4
Breast
4
Sarcoma
1
NET
1
Endocrine
1
Conditions
Sarcoma
959
Glioblastoma
299
Gliosarcoma
288
Osteosarcoma
285
Brain Neoplasms
195
Dendritic Cell Sarcoma, Interdigitating
188
Gastrointestinal Stromal Tumors
180
Bone Neoplasms
172
Lymphoma
160
Central Nervous System Neoplasms
160
Astrocytoma
155
Sarcoma, Ewing
150
Glioma
148
Precursor Cell Lymphoblastic Leukemia-Lymphoma
147
Lymphoma, Non-Hodgkin
143
Burkitt Lymphoma
139
Neoplasms
137
Recurrence
134
Lymphoma, Large B-Cell, Diffuse
128
Lymphoma, Follicular
128
Neuroblastoma
126
Rhabdomyosarcoma
125
Hodgkin Disease
124
Oligodendroglioma
123
Breast Neoplasms
123
Lymphoma, Mantle-Cell
117
Leukemia, Myeloid, Acute
117
Leukemia, Lymphocytic, Chronic, B-Cell
117
Lymphoma, B-Cell, Marginal Zone
113
Leukemia
111
Interventions
Poly(ADP-ribose) Polymerase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Esophageal Squamous Cell Carcinoma
×
Sarcoma
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled